These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2411397)
21. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia. Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360 [TBL] [Abstract][Full Text] [Related]
22. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats. Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971 [TBL] [Abstract][Full Text] [Related]
23. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Catchpoole DR; Stewart BW Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925 [TBL] [Abstract][Full Text] [Related]
24. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro. Liliemark J; Pettersson B; Peterson C Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210 [TBL] [Abstract][Full Text] [Related]
25. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group). Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM; Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274 [TBL] [Abstract][Full Text] [Related]
26. Quantitation of intracellular metabolites of [35S]-6-mercaptopurine in L5178Y cells grown in time-course incubates. Breter HJ; Zahn RK Cancer Res; 1979 Sep; 39(9):3744-8. PubMed ID: 476698 [TBL] [Abstract][Full Text] [Related]
27. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628 [TBL] [Abstract][Full Text] [Related]
28. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related]
29. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside. Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645 [TBL] [Abstract][Full Text] [Related]
31. Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured? Vikingsson S; Carlsson B; Almer SH; Peterson C Ther Drug Monit; 2009 Jun; 31(3):345-50. PubMed ID: 19363461 [TBL] [Abstract][Full Text] [Related]
32. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate. Liliemark JO; Plunkett W Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676 [TBL] [Abstract][Full Text] [Related]
33. Conjugated linoleic acid modulation of cell membrane in leukemia cells. Agatha G; Voigt A; Kauf E; Zintl F Cancer Lett; 2004 Jun; 209(1):87-103. PubMed ID: 15145524 [TBL] [Abstract][Full Text] [Related]
34. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity. Tanaka M; Yoshida S Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933 [TBL] [Abstract][Full Text] [Related]
35. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells. Plunkett W; Benvenuto JA; Stewart DJ; Loo TL Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846 [TBL] [Abstract][Full Text] [Related]
36. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells. Shewach DS; Mitchell BS Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707 [TBL] [Abstract][Full Text] [Related]
37. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442 [TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug. Marsh W; Sicheri D; Center MS Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939 [TBL] [Abstract][Full Text] [Related]
39. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Adamson PC; Poplack DG; Balis FM Leuk Res; 1994 Nov; 18(11):805-10. PubMed ID: 7967706 [TBL] [Abstract][Full Text] [Related]
40. Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate. Giverhaug T; Loennechen T; Aarbakke J Biochem Pharmacol; 1998 May; 55(10):1641-6. PubMed ID: 9634000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]